PDRN skincare: what salmon-DNA serums and Rejuran really do

PDRN stands for polydeoxyribonucleotide: low-molecular-weight fragments of DNA, purified from salmon (typically the milt of chum salmon or salmon trout). The DNA is broken down, filtered, and sterilized so that what remains is the fragment material, not fish cells — which is why it's described as "salmon DNA" rather than "salmon."

The idea behind it is that these DNA fragments act as building-block material and signaling molecules the skin can use — studies commonly discuss anti-inflammatory (soothing) effects and support for tissue repair and blood supply, largely through a receptor pathway (the A2A adenosine receptor). That's the mechanism people mean when they call PDRN "regenerative." It's biologically plausible and supported by early research, not a guarantee of a specific result for any one person.

It's worth being honest about the origin story, because a lot of marketing isn't. PDRN as a molecule was first developed in Italy: the company Mastelli launched an injectable PDRN wound-healing drug (Placentex) in the 1990s, building on university research. So the raw science is European, and it started in medicine, not beauty.

Korea's real contribution was repositioning it. In 2014, Korean company PharmaResearch launched salmon-derived PDRN/PN as an aesthetic skin booster — Rejuran — and Korean dermatology turned "salmon DNA" from a wound drug into a mainstream glow treatment. That's why the trend, the branding, and the global "salmon DNA skincare" wave read as Korean even though the underlying molecule was invented elsewhere.

You'll see both "PDRN" and "PN" on Korean menus and product labels, often used loosely as if they're identical. They're related but not the same — PDRN is essentially a shorter, smaller-fragment member of the polynucleotide family.

This is the distinction that matters most, and where honest information is hardest to find. A PDRN serum and a PDRN injection are not two strengths of the same thing — they mostly do different jobs, and the evidence is very different.

The catch with topical PDRN is size: DNA fragments are large molecules that don't easily pass from the skin's surface into the deeper layers where collagen-making cells live. So a serum realistically works at the surface — hydration, comfort, barrier support — rather than remodeling deep skin the way an injection can. The mechanism is real and early data is promising, but topical PDRN is far less proven than the injectable, and it's fair to treat serum claims with healthy skepticism.

In-clinic injectables (the Rejuran-type "salmon DNA" boosters) place PDRN/PN directly into the skin, and this is where the better evidence sits: small clinical studies suggest improvements in skin elasticity, texture, and quality, with a generally favorable short-term safety profile — though long-term, standardized data is still limited. A doctor confirms whether it's suitable for you.

In consultations and coverage, PDRN comes up most for people focused on overall skin quality rather than reshaping the face — dullness, fine texture, dehydrated or stressed skin, and post-procedure soothing. It's a "condition of the skin" treatment, not a volumizer or a muscle relaxer (see our guide comparing K-beauty treatments for how it sits next to filler, Botox, and lasers).

Suitability is individual, and some situations — pregnancy, breastfeeding, a fish or salmon allergy, active skin infections — call for extra caution or ruling it out. That's exactly what a doctor consultation is for; don't self-prescribe an injectable off a trend.